EarliTec Diagnostics vs MeMed
EarliTec Diagnostics vs MeMed, compared side by side on 23 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: EarliTec Diagnostics is on 52/100 and MeMed on 61/100.
Where each one leads
EarliTec Diagnostics
- agent readiness: 47/100 against 35/100
- headcount growth: +13.2% against -8.4%
MeMed
- our overall score: 61/100 against 52/100
- domain rating: 46/100 against 40/100
- headcount: 99 against 38
- funding raised: $196M against $41.0M
- LinkedIn following: 21,207 against 2,037
At a glance
| Measure | EarliTec Diagnostics | MeMed |
|---|---|---|
| What it is | EarliPoint Health develops a digital health platform for earlier identification and treatment of autism spectrum disorder (ASD) in children. | MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes. |
| Category | Healthcare, Autism, Diagnostics, HealthTech | Healthcare, Blood, Diagnostics, MedTech |
| Sells toBusiness model | B2B | B2B, B2G |
| Offering | Platform | Software, Hardware |
| Founded | 2019 | 2009 |
| Headquarters | Atlanta, United States | Tirat Carmel, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | EarliTec Diagnostics | MeMed |
|---|---|---|
| Employees | 38 | 99 |
| Headcount growthLast 12 months | +13.2% | -8.4% |
| Total funding | $41.0M | $196M |
| Latest round | Series B | Series E |
| LinkedIn followers | 2,037 | 21,207 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | EarliTec Diagnostics | MeMed |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 52/100 | 61/100 |
| Traction | 54/100 | 60/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 33/100 | 29/100 |
| Quality | 58/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 46/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | EarliTec Diagnostics | MeMed |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
| Analytics | Google Tag Manager | Google Analytics 4, Google Tag Manager |
EarliTec Diagnostics vs MeMed: common questions
Which is better, EarliTec Diagnostics or MeMed?
On our 0-100 score MeMed rates higher (61/100 against 52/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 23 data points above: read the rows that match what you are buying for.
How do EarliTec Diagnostics and MeMed compare on the numbers?
EarliTec Diagnostics leads on agent readiness (47/100 against 35/100), headcount growth (+13.2% against -8.4%). MeMed leads on our overall score (61/100 against 52/100), domain rating (46/100 against 40/100), headcount (99 against 38), funding raised ($196M against $41.0M), LinkedIn following (21,207 against 2,037).
Read the full EarliTec Diagnostics review and pricing or the MeMed review and pricing. You can also browse other EarliTec Diagnostics alternatives we track.